US Patent Trial and Appeal Board didn't violate APA in review of Remodulin patent, Federal Circuit rules
While stopping short of agreeing with the US Patent and Trademark Office and Liquidia Technologies that an affirmation of truthfulness is waivable by the Patent Trial and Appeal Board, a federal...To view the full article, register now.
Already a subscriber? Click here to view full article